Answer
Each 0.5 mL dose of the 2026/2027 Cell-based Trivalent Influenza Vaccine Seqirus contains 15 micrograms of haemagglutinin from each of the A/Missouri/11/2025 (H1N1)pdm09-like, A/Darwin/1415/2025 (H3N2)-like and B/Pennsylvania/14/2025-like strains.
Sources for this answer
- Cell-based Trivalent Influenza Vaccine SeqirusSeqirus UK Limited · emc · SmPC §2 Qualitative and quantitative composition · Version 4Document updated
Sources checked